logo

For the Inventor, By the Inventor

Tainan, Taiwan

Wen-Yang Lin

USPTO Granted Patents = 9

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:

goldMedal9 out of 23 
 
Glac Biotech Co., Ltd.
 patents

Years Active: 2023-2024

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12005091 - Use of lactic acid bacteria or fermentation product thereof for maintaining or improving gastrointestinal condition (2024-06-11),
2. 12005090 - Probiotic composition including lactic acid bacterial strains and use of at least one of such strains (2024-06-11),
3. 11957722 - Anti-aging composition and use thereof for preventing aging (2024-04-16),
4. 11913047 - Method for producing γ-aminobutyric acid and fermented culture prepared thereby (2024-02-27),
5. 11911421 - Probiotic composition including lactic acid bacterial strains and use thereof (2024-02-27),
6. 11896632 - Methods for inhibiting growth of oral pathogenic bacteria and alleviating oral pathogenic bacteria-associated disorder (2024-02-13),
7. 11779615 - Lactic acid bacteria composition for reducing fat and promoting exercise performance and use thereof (2023-10-10),
8. 11759487 - Composition including probiotics and method of increasing amount of oral immunoglobulin A and inhibiting oral pathogens by administering the same (2023-09-19),
9. 11730779 - Lactic acid bacterial composition for treating or preventing jaundice (2023-08-22),

Title: The Innovative Mind of Wen-Yang Lin

Introduction

Wen-Yang Lin, an accomplished inventor based in Tainan, Taiwan, has made significant contributions to the field of biotechnology. With a portfolio of nine patents, Lin is recognized for his innovative approaches to improving gastrointestinal health through the use of lactic acid bacteria.

Latest Patents

Among his latest patents, Lin has developed a groundbreaking method that utilizes lactic acid bacteria to maintain or improve gastrointestinal condition. This invention involves administering a composition containing the aET-66 strain, identified with deposition number CGMCC 13514. Furthermore, he has pioneered a probiotic composition that includes lactic acid bacterial strains such as subsp.AP-32 and subsp.OLP-01. The strains are deposited at notable culture collection centers, CCTCC and CGMCC, respectively. Lin's research offers new avenues for treating obesity and related disorders by inhibiting fat absorption.

Career Highlights

Wen-Yang Lin is currently affiliated with Glac Biotech Co., Ltd. His work is consistently characterized by a commitment to advancing the science of probiotics and their applications in gut health and obesity management.

Collaborations

Lin collaborates with fellow researchers, including Hsieh-Hsun Ho and Yi-Wei Kuo, who contribute diverse expertise to their projects. These collaborations enhance the innovative potential of their research, leading to impactful developments in biotechnology.

Conclusion

Wen-Yang Lin is a notable figure in innovation and invention within the biotechnology sector. His dedication to improving gastrointestinal health through lactic acid bacteria positions him at the forefront of research aimed at addressing critical health issues, making him an invaluable asset to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…